Equities

GuangYuYuan Chinese Herbal Medicine Co Ltd

600771:SHH

GuangYuYuan Chinese Herbal Medicine Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)16.33
  • Today's Change-0.18 / -1.09%
  • Shares traded3.12m
  • 1 Year change-44.66%
  • Beta1.6532
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments257244101
Total Receivables, Net8401,0911,611
Total Inventory570415353
Prepaid expenses111116
Other current assets, total4.762.4544
Total current assets1,6821,7642,125
Property, plant & equipment, net707710738
Goodwill, net00--
Intangibles, net9499101
Long term investments282930
Note receivable - long term------
Other long term assets191939
Total assets2,6282,7013,102
LIABILITIES
Accounts payable76157178
Accrued expenses724833
Notes payable/short-term debt124320560
Current portion long-term debt/capital leases1966412
Other current liabilities, total57646990
Total current liabilities1,0441,057873
Total long term debt3920470
Total debt359588642
Deferred income tax142.702.81
Minority interest129.2541
Other liabilities, total241415
Total liabilities1,1321,2871,003
SHAREHOLDERS EQUITY
Common stock489489492
Additional paid-in capital1,5881,5881,637
Retained earnings (accumulated deficit)(579)(669)17
Treasury stock - common----(51)
Unrealized gain (loss)(5.37)2.701.68
Other equity, total2.852.852.85
Total equity1,4961,4142,099
Total liabilities & shareholders' equity2,6282,7013,102
Total common shares outstanding489489489
Treasury shares - common primary issue002.51
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.